Technology News and Research

RSS

Diamyd Medical completes enrollment in NP2 Enkephalin Phase II study for cancer pain

The last study participant has been recruited to Diamyd Medical's Phase II study in which cancer pain is treated with the drug candidate NP2 Enkephalin. The study is thus fully enrolled and results are expected to be reported in five to seven weeks.

22 May 2012

Enrollment complete in Xencor, MorphoSys’ MOR208 phase 1 trial for CLL

MorphoSys AG and US-based Xencor, Inc. today announced the successful completion of patient enrollment in the phase 1 clinical trial evaluating MOR208.

22 May 2012

Polarization Gating Spectroscopy may detect pancreatic cancer

By simply shining a tiny light within the small intestine, close to that organ's junction with the pancreas, physicians at Mayo Clinic's campus in Florida have been able to detect pancreatic cancer 100 percent of the time in a small study.

22 May 2012

FSU announces availability of Pacifier Activated Lullaby device

Many premature babies enter the world with a mountain of challenges in front of them. Even after they overcome any life-threatening issues, they face ongoing, and typically unpleasant, medical procedures, long hospital stays and increased chances of chronic health issues throughout their lives.

22 May 2012

TransCytos, Enginasion collaborate to develop new transfection technology

Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.

22 May 2012

FDA clears Teleflex’s ARROW PICC with Chloragard technology

Teleflex Incorporated announced today that in addition to broad-spectrum antimicrobial protection, the pressure-injectable ARROW PICC with Chloragard Technology provides antithrombogenic protection for at least 30 days.

22 May 2012

CSA Medical unveils new truFreeze Spray Cryotherapy System

CSA Medical, Inc. unveiled the new truFreeze Spray Cryotherapy System this week at the Digestive Disease Week (DDW) 2012 Annual Meeting in San Diego.

21 May 2012

Male cyclists may experience hormonal imbalances that affect reproductive health

A new study conducted by UCLA School of Nursing researchers has found that serious leisure male cyclists may experience hormonal imbalances that could affect their reproductive health. The study, "Reproductive Hormones and Interleukin-6 in Serious Leisure Male Athletes," was published in the European Journal of Applied Physiology.

21 May 2012

New optical microscope sees individual blood cells as they flow inside the body

Blood tests convey vital medical information, but the sight of a needle often causes anxiety and results take time. A new device developed by a team of researchers in Israel, however, can reveal much the same information as traditional blood test in real-time, simply by shining a light through the skin.

21 May 2012

New trial on home oxygen therapy for patients with chronic heart failure

Researchers at the University of Hull, in the UK, have just launched a major new trial investigating the effects of home oxygen therapy in patients with chronic heart failure (CHF).

21 May 2012

Regenerative medicine researchers explore innovative ways to treat childhood conditions

About 3 percent of the babies born in the United States have a birth defect. Children without a birth defect are also susceptible to injury or disease. At The University of Texas Health Science Center at Houston (UTHealth), regenerative medicine researchers are exploring innovative ways to treat these conditions.

21 May 2012

Aushon plans global launch of new multiplex protein biomarker platform

Aushon announced its plans today for an upcoming global launch of its new multiplex protein biomarker platform, which incorporates several engineering breakthroughs to deliver ELISA-level performance.

21 May 2012

Cook Medical introduces drug-eluting peripheral stent to treat lesions in the SFA

Cook Medical, a world leader in minimally invasive medical technologies, has launched a first-of-its-kind drug-eluting peripheral stent in Australia, the Zilver PTX Drug-Eluting Peripheral Stent.

21 May 2012

New supplements safety guide for athletes

The U.S. Anti-Doping Agency (USADA) recently released a new supplements safety guide for athletes as part of their "Supplement 411" initiative.

21 May 2012

SERVE-HF study on effect of CSA treatment for stable heart failure enrolls 1,000th participant

SERVE-HF, the largest study to investigate if treatment of predominant central sleep apnea (CSA) improves survival and outcomes of patients with stable heart failure, has enrolled its 1,000th participant. The study, sponsored by ResMed Ltd., is the largest of its kind. This milestone brings the SERVE-HF study, which began in 2008, one step closer to its target of approximately 1,250 participants.

From ResMed Corp 21 May 2012

BIOCRATES Life Sciences to introduce AbsoluteIDQ p180 and p150 research kits

Austrian BIOCRATES Life Sciences AG, prime developer of state-of-the-art metabolite biomarker panels, is about to launch new editions of two of its well-established research kit products -AbsoluteIDQ p180 and p150.

21 May 2012

DATATRAK wins 2012 Crain's Leading EDGE award

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the Company's selection as a 2012 Crain's Leading EDGE award winner; this is DATATRAK's third consecutive year to be honored.

21 May 2012

The Patient Status Engine™ – Industry’s First Cloud-Based Wireless Sensor Vigilance System for Real-time and Predictive Patient Status – Introduced by Isansys

Isansys Lifecare Limited, the provider of complete real-time physiological patient data services and systems, today announces the introduction of its Patient Status Engine™ – the first cloud-based patient digitization and analytic solution for monitoring and predicting the present and future clinical status of patients anytime, anywhere. The introduction of the Patient Status Engine provides the platform for Isansys’ “Vitals as a Service™” solution, which is now offered for priority beta deployments in hospitals and other healthcare facilities.

From Isansys Lifecare Ltd. 21 May 2012

Clifix opts for Leo Technosoft’s multi tenancy framework “SaaS-Tenant™”– touted to revolutionize the healthcare sector

Taking the industry by storm Clifix has vouched for Leo Technosoft’s “SaaS-Tenant™”, a brand that’s a leading name in cloud based multi tenancy framework to develop their pioneering practice management system. The innovative practice management system is touted to completely revolutionize the functioning of the healthcare sector. Bidding goodbye to the outdated methods, this ground-breaking technology is built on the “SaaS-Tenant™”architecture enabling speedy data mining and improved usability.

21 May 2012

First study to test safety of quantum dots in primates

A pioneering study to gauge the toxicity of quantum dots in primates has found the tiny crystals to be safe over a one-year period, a hopeful outcome for doctors and scientists seeking new ways to battle diseases like cancer through nanomedicine.

21 May 2012

Technology News and Research

Diamyd Medical completes enrollment in NP2 Enkephalin Phase II study for cancer pain

Enrollment complete in Xencor, MorphoSys’ MOR208 phase 1 trial for CLL

Polarization Gating Spectroscopy may detect pancreatic cancer

FSU announces availability of Pacifier Activated Lullaby device

TransCytos, Enginasion collaborate to develop new transfection technology

FDA clears Teleflex’s ARROW PICC with Chloragard technology

CSA Medical unveils new truFreeze Spray Cryotherapy System

Male cyclists may experience hormonal imbalances that affect reproductive health

New optical microscope sees individual blood cells as they flow inside the body

New trial on home oxygen therapy for patients with chronic heart failure

Regenerative medicine researchers explore innovative ways to treat childhood conditions

Aushon plans global launch of new multiplex protein biomarker platform

Cook Medical introduces drug-eluting peripheral stent to treat lesions in the SFA

New supplements safety guide for athletes

SERVE-HF study on effect of CSA treatment for stable heart failure enrolls 1,000th participant

BIOCRATES Life Sciences to introduce AbsoluteIDQ p180 and p150 research kits

DATATRAK wins 2012 Crain's Leading EDGE award

The Patient Status Engine™ – Industry’s First Cloud-Based Wireless Sensor Vigilance System for Real-time and Predictive Patient Status – Introduced by Isansys

Clifix opts for Leo Technosoft’s multi tenancy framework “SaaS-Tenant™”– touted to revolutionize the healthcare sector

First study to test safety of quantum dots in primates

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News